Augmentation of HIV-1 subtype C vaccine constructs induced immune response in mice by CpG motif 1826-ODN

Viral Immunology

Volumn 18, Issue 1, 2005, Pages 213-223

  Aggarwal, Priya ^a   Pandey, R M ^a   Seth, Pradeep ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAG PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; OLIGONUCLEOTIDE; PLASMID DNA; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; ENVELOPE GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE C; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PROTEIN MOTIF;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; DISEASE MODELS, ANIMAL; DNA; FEMALE; GENE PRODUCTS, GAG; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV PROTEASE; HIV-1; MICE; MICE, INBRED BALB C; VACCINES, DNA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 17844374356     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2005.18.213     Document Type: Article

References (29)

1. André, S., B. Seed, J. Eberle, et al. 1998. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72:1497-1503.
2. Arora, A., J.L. Fahey, and P. Seth. 2001. DNA vaccine for the induction of immune responses against HIV-1 subtype C envelope gene in mice. Gene Ther. Mol. Biol. 6:79-89.
3. Barouch, D.H., S. Santra, T.D. Steenbeke, et al. 1998. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J. Immunol. 161:1875-1882.
4. Brown, W.C., D.M. Estes, S.E. Chantler, et al. 1998. DNA and a CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells. Infect. Immun. 66:5423-5432.
5. Chattergoon, M., J. Boyer, and D.B. Weiner. 1997. Genetic immunization: a new era in vaccines and immune therapeutics. FASEB J. 11:753-763.
6. Chugh, P., and P. Seth. 2003. Cloning of gag gene of HIV-1 subtype c (Indian strain) into a mammalian expression vector and in vitro expression studies. IJMM 21:77-81.
7. Chugh, P., and P. Seth. 2004. Induction of broad based immune response against HIV-1 subtype C gag DNA vaccine in mice. Viral Immunol. 17:423-435.
8. Cluskie, M.J., and H.L. Davis. 1998. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J. Immunol. 161:4463-4466.
9. Hartmann, G., and A.M. Krieg. 2000. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164:944-953.
10. Hartmann, G., R.D. Weeratna, Z.K. Ballas, et al. 2000. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164:1617-1624.
11. Iwasaki, A., B.J. Stiernholm, A.K. Chan, et al. 1997. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158:4591-4601.
12. Jakob, T., S.W. Patricia, A.M. Krieg, et al. 1998. Activation of cutaneous dendritic cells by CpG containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161:3042-3049.
13. Kalams, S.A., S.P. Buchbinder, E.S. Rosenberg, et al. 1999. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. Leukemia 13(Suppl 1):42-47.
14. Kim, J.J., M.L. Bagarazzi, N. Trivedi, et al. 1997. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat. Biotechnol. 15:641-646.
15. Kobayashi, H., A.A. Horner, K. Takabayashi, et al. 1999. Immunostimulatory DNA pre-priming: a novel approach for prolonged Th1-biased immunity. Cell Immunol. 198: 069-75.
16. Kojima, Y., K.Q. Xin, T. Ooki, et al. 2002. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine 23-24:2857-2865.
17. Koup, R.A., J.T. Safrit, Y. Cao, et al. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency. J. Virol. 68:4650-4655.
18. Krieg, A.M., J. Tonkinson, S. Matson, 1993. Modification of antisense phosphodiester oligodeoxynucleotides by a 5′ cholesteryl moiety increases cellular association and improves efficacy. Proc. Natl. Acad. Sci. USA 90:1048-1052.
19. Krieg, A.M., A.K. Yi, S. Matson, et al. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:6546-6549.
20. Liang, H., Y. Nishioka, C.F. Reich, et al. 1996. Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98:1119-1129.
21. Ogg, G.S., X. Jin, S. Bonhoeffer, et al. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103-2106.
22. Rankin, R., R. Pontarollo, X. Iannou, et al. 2001. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 11:333-340.
23. Richmond, J.F., F. Mustafa, S. Lu, et al. 1997. Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody by DNA immunization and recombinant Vaccinia virus boosting. Virology 230:265-274.
24. Scott, A.H., V.N. Gary, S. Bruce, et al. 2003. A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen coadministered with an immunostimulatory phosphorothioate oligonucleotide adjuvant. Vaccine 21:2461-2467.
25. Shan, L., J.C. Santoro, D.H. Fuller, et al. 1995. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 209:147-154.
26. Tang, D.C., M. DeVit, and S.A. Johnston. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356:152-154.
27. Ulmer, J.B., J.J. Donnelly, S.E. Parker, et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
28. Verthelyi, D., M. Gursel, R.T. Kenney, et al. 2003. CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection. J. Immunol. 170: 4717-4723.
29. Verthelyi, D., R.T. Kenney, R.A. Seder, et al. 2002. CpG oligodeoxynucleotides as vaccine adjuvants in primates. J. Immunol. 168:1659-1663.